Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00011492Terminated
Patient Evaluation for Head and Neck Surgery Branch Studies
Carcinoma, Squamous CellHead and Neck NeoplasmsLaryngeal Cancer+2 more
PrincipalinvestigatorStart date: 2001-03-12
NCT00011778Phase 1Completed
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
Squamous Cell Carcinoma
Principalinvestigator
NCT01445405Phase 1Completed
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Carcinoma, SquamousHead and Neck CancerLaryngeal Cancer+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Institute on Deafness and Other Communication Disorders (NIDCD)

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Douglas Adkins, M.D.

Washington University School of Medicine

Related
11 trials

Shared therapeutic areas:

Head and Neck NeoplasmsCancer of Head and NeckCarcinoma, Squamous Cell
Similarity Score15%

Nancy Lee, MD

Memorial Sloan Kettering Cancer Center

Related
18 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Squamous Cell

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of Head and NeckCarcinoma, Squamous Cell
Similarity Score10%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Head and Neck Neoplasms
Similarity Score5%

Scot C. Remick, MD

Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center

Related
13 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Cancer of Head and Neck

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Carcinoma, Squamous Cell
Similarity Score5%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Carcinoma, Squamous Cell
Similarity Score5%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Cancer of Head and Neck
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00011492PrincipalInvestigator

Patient Evaluation for Head and Neck Surgery Branch Studies

Carcinoma, Squamous CellHead and Neck NeoplasmsLaryngeal Cancer+2 more
Terminated
NCT00011778Phase 1PrincipalInvestigator

PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck

Squamous Cell Carcinoma
Completed
NCT01445405Phase 1PrincipalInvestigator

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

Carcinoma, SquamousHead and Neck CancerLaryngeal Cancer+2 more
Completed

All 3 trials loaded